KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Accounts Payables (2016 - 2026)

Edwards Lifesciences has reported Accounts Payables over the past 17 years, most recently at $227.5 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 15.25% year-over-year to $227.5 million; the TTM value through Dec 2025 reached $227.5 million, up 15.25%, while the annual FY2025 figure was $227.5 million, 15.25% up from the prior year.
  • Accounts Payables for Q4 2025 was $227.5 million at Edwards Lifesciences, up from $165.0 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $861.1 million in Q2 2021 and troughed at $139.5 million in Q3 2021.
  • A 5-year average of $245.1 million and a median of $186.2 million in 2023 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: crashed 83.03% in 2021 and later rose 23.05% in 2023.
  • Year by year, Accounts Payables stood at $204.5 million in 2021, then decreased by 1.27% to $201.9 million in 2022, then fell by 7.58% to $186.6 million in 2023, then grew by 5.79% to $197.4 million in 2024, then rose by 15.25% to $227.5 million in 2025.
  • Business Quant data shows Accounts Payables for EW at $227.5 million in Q4 2025, $165.0 million in Q3 2025, and $162.1 million in Q2 2025.